APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $60,764 | -30.9% | 667 | -50.0% | 0.01% | -38.5% |
| Q1 2023 | $87,925 | +27.6% | 1,333 | 0.0% | 0.01% | +18.2% |
| Q4 2022 | $68,929 | -24.3% | 1,333 | 0.0% | 0.01% | -26.7% |
| Q3 2022 | $91,000 | +51.7% | 1,333 | 0.0% | 0.02% | +50.0% |
| Q2 2022 | $60,000 | +5.3% | 1,333 | +19.8% | 0.01% | +25.0% |
| Q1 2022 | $57,000 | -5.0% | 1,113 | -12.2% | 0.01% | 0.0% |
| Q4 2021 | $60,000 | +81.8% | 1,267 | +25.1% | 0.01% | +100.0% |
| Q3 2021 | $33,000 | +10.0% | 1,013 | +113.3% | 0.00% | 0.0% |
| Q2 2021 | $30,000 | – | 475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |